Frazier Financial Advisors LLC Takes $149,000 Position in agilon health, inc. (NYSE:AGL)

Frazier Financial Advisors LLC bought a new stake in shares of agilon health, inc. (NYSE:AGL) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 11,903 shares of the company’s stock, valued at approximately $149,000.

A number of other large investors have also recently modified their holdings of AGL. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of agilon health by 17.9% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,452 shares of the company’s stock valued at $274,000 after purchasing an additional 2,349 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of agilon health by 13.5% during the 3rd quarter. Principal Financial Group Inc. now owns 34,260 shares of the company’s stock valued at $608,000 after purchasing an additional 4,088 shares in the last quarter. California Public Employees Retirement System boosted its stake in shares of agilon health by 27.7% during the 3rd quarter. California Public Employees Retirement System now owns 413,987 shares of the company’s stock valued at $7,352,000 after purchasing an additional 89,728 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its stake in shares of agilon health by 128.6% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 6,820 shares of the company’s stock valued at $121,000 after purchasing an additional 3,837 shares in the last quarter. Finally, Signaturefd LLC boosted its stake in shares of agilon health by 73.7% during the 3rd quarter. Signaturefd LLC now owns 1,673 shares of the company’s stock valued at $30,000 after purchasing an additional 710 shares in the last quarter.

agilon health Stock Performance

Shares of AGL traded up $0.44 during mid-day trading on Wednesday, hitting $5.99. 4,912,134 shares of the company traded hands, compared to its average volume of 5,423,889. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.33 and a current ratio of 1.33. The stock has a 50-day moving average price of $5.22 and a two-hundred day moving average price of $7.82. agilon health, inc. has a 1 year low of $4.41 and a 1 year high of $21.52. The stock has a market cap of $2.46 billion, a price-to-earnings ratio of -8.56 and a beta of 0.52.

agilon health (NYSE:AGL) last released its quarterly earnings data on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.13). agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. The company had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the previous year, the firm earned ($0.14) earnings per share. The firm’s revenue for the quarter was up 71.8% on a year-over-year basis. Equities analysts anticipate that agilon health, inc. will post -0.35 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Citigroup assumed coverage on shares of agilon health in a research note on Monday, April 22nd. They set a “neutral” rating and a $6.00 price objective on the stock. TD Cowen lowered shares of agilon health from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $12.00 to $6.50 in a research note on Monday, February 26th. Jefferies Financial Group reissued a “hold” rating and set a $6.50 price objective (down previously from $25.00) on shares of agilon health in a research note on Monday, February 26th. Royal Bank of Canada dropped their price objective on shares of agilon health from $11.00 to $8.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 28th. Finally, Stifel Nicolaus dropped their price objective on shares of agilon health from $8.00 to $7.00 and set a “hold” rating on the stock in a research note on Wednesday, May 1st. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, agilon health currently has a consensus rating of “Hold” and a consensus target price of $9.32.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.